From Wikipedia, the free encyclopedia
Jump to navigationJump to search
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This biography of a living person needs additional citations for verification. (October 2019)
A major contributor to this article appears to have a close connection with its subject. (September 2019)
Born Adar Cyrus Poonawalla
Alma mater Bishops School (Pune),
St. Edmund’s School,Canterbury Kent (UK),
University of Westminster
Organization Serum Institute of India
Known for Chief Executive Officer of Serum Institute of India, Horse Racing, Cars
Spouse(s) Natasha Poonawalla
Children Cyrus (Son) , Darius (Son)
Website www.adarpoonawalla.com www.cyruspoonawallagroup.com
Adar Poonawalla (born 14 January 1981) the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Dr. Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.
Adar Poonawalla was educated at the Bishops School (Pune), St. Edmund's School, Canterbury Kent (UK) followed by the University of Westminster (UK).
5 External links
Adar Poonawalla joined Serum Institute in 2001 after graduating from the University of Westminster in London. Then exporting its products to 35 countries, Poonawalla concentrated on the company's international market and getting new products licensed and pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. As of 2015, the company exports its products to over 140 countries; 85 percent of its revenues are from overseas.
In 2011, he became the CEO of Serum Institute of India with full control of day-to-day operations of the company. In 2012 he played a major role in the acquisition of Bilthoven Biologicals a Netherlands-based government vaccine manufacturing company. In 2017 he acquired Praha Vaccine Limited in the Czech Republic. Poonawalla is a board member of the GAVI Alliance, the global vaccine alliance.
He initiated and launched in 2014 Serum Institute's oral polio vaccine, which became a bestseller for the company. Every year he plans to launch a new vaccines for public health starting in 2017. In 2014, it was reported that he planned to expand the product portfolio to include vaccines for dengue, flu and cervical cancer.